Spiroketal Derivatives Multi-Target Bioactivity via Local Functionalization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bio-discovery methods lack effective bioactive molecules with therapeutic benefits for treatments such as cancer, antiprotozoal, antiparasitic, antibiotic, anti-inflammatory, and pesticidal applications.
Innovation Solution
Development of new spiroketal derivatives with specific structural formulas that act as cytotoxic, antiprotozoal, antiparasitic, antibiotic, anti-inflammatory, or immunosuppressive agents, potentially usable in pharmaceutical or agricultural contexts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If new spiroketal derivatives are developed to provide broad therapeutic benefits, then the spectrum of bioactive properties is improved, but the complexity of molecular structure increases
Solution Approach 1:
The spiroketal core structure serves as a multi-functional platform that can exhibit diverse bioactivities including cytotoxic, antiprotozoal, antiparasitic, antibiotic, anti-inflammatory, and immunosuppressive properties. By designing a central spiroketal scaffold with multiple substitution positions, the molecule can simultaneously or selectively interact with different biological targets, achieving broad therapeutic benefits from a single molecular architecture
Solution Approach 2:
The patent employs local functionalization of the spiroketal core by introducing specific substituents at defined positions (R1-R28) to modulate and direct specific bioactivities. Each substituent can be independently optimized to provide localized functional properties, allowing the molecule to engage with different biological systems through specific local interactions while maintaining the overall spiroketal framework
2Adaptability or versatility
If spiroketal derivatives are designed for multiple therapeutic applications, then the range of treatments is improved, but the difficulty of synthesis and isolation increases
Solution Approach 1:
The spiroketal molecule is divided into a core scaffold (the spiroketal ring system) and multiple independent substituent positions (R1-R28). This segmentation allows the core structure to be synthesized once and then systematically modified at different positions to create various derivatives for different therapeutic applications, streamlining the development process for multiple treatments from a single core synthesis pathway
Solution Approach 2:
The patent systematically varies the parameters of substitution at different positions on the spiroketal core to optimize for different therapeutic indications. By changing the chemical nature, size, and position of substituents, the molecule can be tuned for specific applications (cytotoxic, antiprotozoal, antibiotic, etc.) while following a consistent synthetic framework based on the core spiroketal structure
Data Source
AI summary
The present invention relates to spiroketal compounds that are useful in methods of treating or preventing protozoal infections, parasitic infections, bacterial infections, cell proliferative disorders and anti inflammatory disorders. The spiroketal compounds are also useful as immunosuppressive agents, and also in methods of controlling pests.